Structures by: Reibarkh M.
Total: 6
Doravirine
C17H11ClF3N5O3
Molecular pharmaceutics (2020)
a=7.9899(5)Å b=10.1223(6)Å c=11.6441(7)Å
α=101.878(2)° β=104.712(2)° γ=97.380(2)°
Isopropyl ((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-2-(hydroxymethyl)-4-methyltetrahydrofuran-3-yl)oxy)(phenoxy)phosphoryl)-D-alaninate
C22H29FN3O9P
Chem. Sci. (2017) 8, 4 2804
a=11.355(3)Å b=13.612(3)Å c=16.835(4)Å
α=90° β=90° γ=90°
Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-D-alaninate
C18H17F5NO5P
Chem. Sci. (2017) 8, 4 2804
a=5.2533(2)Å b=12.0015(5)Å c=16.3874(7)Å
α=74.879(2)° β=84.088(2)° γ=80.148(2)°
(η^2^,η^2^-Tetraphenylcyclopentadienone)-tricarbonyl-iron methylene chloride solvate
C32H20Fe1O4,C1H2Cl2
Journal of the American Chemical Society (2018) 140, 42 13843-13853
a=10.2420(2)Å b=11.6419(2)Å c=23.9124(5)Å
α=90° β=102.0253(10)° γ=90°
(S)-3-((2R,5S)-5-(4-fluorophenyl)-2-((S)-((4-iodophenyl)amino) (4-((trimethylsilyl)oxy) phenyl)methyl)-5-((trimethylsilyl)oxy) pentanoyl)-4-phenyloxazolidin-2-one
C39H46FIN2O5Si2
The Journal of organic chemistry (2016) 81, 2 723-728
a=5.7152(3)Å b=15.4683(7)Å c=22.7213(10)Å
α=81.5151(14)° β=89.5040(16)° γ=89.5445(14)°
(S)-3-((2R,5S)-2-((S)-(4-bromophenyl)((4-iodophenyl)amino)methyl) -5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
C33H29BrFIN2O4
The Journal of organic chemistry (2016) 81, 2 723-728
a=30.3461(12)Å b=5.8463(2)Å c=34.0783(13)Å
α=90° β=96.5700(19)° γ=90°